This invention relates to a method for analyzing the concentration of an analyte in a sample and to automatic analyzing apparatus. The invention will be described herein with particular reference to a method and apparatus for measuring the concentration of glucose or other analytes in blood but is not limited to that use.

Patent
   6852212
Priority
Aug 13 1997
Filed
Oct 02 2001
Issued
Feb 08 2005
Expiry
Aug 13 2018
Assg.orig
Entity
Large
108
128
EXPIRED
17. An automatic analyzing apparatus comprising:
a first electrode,
means for placing a predetermined volume of a liquid sample in contact with the first electrode,
means for bringing a second electrode into a closely spaced relationship with the first electrode after a predetermined volume of a liquid sample has been brought in contact with the first electrode, thereby contacting the sample with the second electrode spaced from the first,
means for applying a potential between the electrodes, and
means for measuring the current as a function of time while the electrodes are in sufficiently close proximity that reaction products formed at one electrode diffuse to the other and achieve a steady state distribution wherein at least one electrode is on a flexible backing.
16. An automatic analyzing apparatus comprising:
a first electrode,
means for placing a predetermined volume of a liquid sample in contact with the first electrode,
means for bringing a second electrode into a closely spaced relationship with the first electrode after a predetermined volume of a liquid sample has been brought in contact with the first electrode, thereby contacting the sample with the second electrode spaced from the first,
means for applying a potential between the electrodes, and
means for measuring the current as a function of time while the electrodes are in sufficiently close proximity that reaction products formed at one electrode diffuse to the other and achieve a steady state distribution wherein at least one electrode is in the form of a continuous strip.
18. An automatic analyzing apparatus comprising:
a first electrode,
means for placing a predetermined volume of a liquid sample in contact with the first electrode,
means for bringing a second electrode into a closely spaced relationship with the first electrode after a predetermined volume of a liquid sample has been brought in contact with the first electrode, thereby contacting the sample with the second electrode spaced from the first,
means for applying a potential between the electrodes, and
means for measuring the current as a function of time while the electrodes are in sufficiently close proximity that reaction products formed at one electrode diffuse to the other and achieve a steady state distribution wherein at least one of the first electrode and the second electrode is mounted on a carousel.
7. An automatic analyzing apparatus comprising:
a first electrode,
means for placing a predetermined volume of a liquid sample in contact with the first electrode,
means for bringing a second electrode into a closely spaced relationship with the first electrode after a predetermined volume of a liquid sample has been brought in contact with the first electrode, thereby contacting the sample with the second electrode spaced from the first,
means for applying a potential between the electrodes, and
means for measuring the current as a function of time while the electrodes are in sufficiently close proximity that reaction products formed at one electrode diffuse to the other and achieve a steady state distribution wherein a volume intermediate the electrode surfaces when the current is measured is not contained by a cell.
1. A method for estimating the concentration of a reduced or oxidized form of a redox species in a liquid comprising the steps of:
(1) contacting an area of a first electrode with a sample of predetermined volume of the liquid,
(2) bringing a second electrode into a closely spaced relationship with the first electrode, thereby contacting the sample with an area of the second electrode spaced apart from the first, wherein step (2) is conducted after step (1),
(3) applying a potential between the electrodes while the electrodes are sufficiently closely spaced that reaction products formed at each electrode diffuse to the other electrode while the potential is applied,
(4) measuring or estimating a value indicative of the change in current as a function of time and a value indicative of the steady state current, and
(5) determining from said value, said current as a function of time, and said steady state current the concentration of reduced or oxidized form of the species in the liquid sample wherein at least one of the electrodes is in the form of a continuous strip.
2. A method according to claim 1 wherein at least one of the electrodes is preprinted with at least one reagent.
3. A method according to claim 1 wherein at least one electrode is covered with a layer which serves to define wells on the electrode surface.
4. Apparatus according to claim 1, further comprising a pipette for depositing a drop of a predetermined volume of sample on the first electrode.
5. The method according to claim 1, wherein the first electrode comprises a first metallized electrode layer, wherein the second electrode comprises a second metallized electrode layer, and wherein the first metallized electrode layer travels transversely of the second electrode layer.
6. The method according to claim 1, wherein the first electrode comprises a first metallized electrode layer, wherein the second electrode comprises a second metallized electrode layer, and wherein the first metallized electrode layer travels in a same direction as the second electrode layer.
8. Apparatus according to claim 7 wherein the first electrode further comprises a porous medium wherein the predetermined volume is immobilized.
9. Apparatus according to claim 7 wherein at least one of the electrodes is a palladium layer.
10. Apparatus according to claim 7 further comprising a pipette for depositing a predetermined volume of sample in contact on the first electrode.
11. Apparatus according to claim 7 further comprising means for depositing one or more reagents on one of the electrodes prior to placing the sample on the electrode.
12. Apparatus according to claim 7, wherein the first electrode further comprises a well defining layer, the well defining layer comprises an aperture, the aperture defining a well.
13. Apparatus according to claim 7, wherein the first electrode or the second electrode further comprises a predetermined quantity of a chemical reagent.
14. Apparatus according to claim 7, wherein at least one of the first electrode and the second electrode is in the form of a disposable probe.
15. Apparatus according to claim 7, wherein at least one of the first electrode and the second electrode is in the form of a retractable probe.

This application is a continuation of application Ser. No. 09/502,907, filed Feb. 11, 2002 and issued as U.S. Pat. No. 6,325,917 on Dec. 4, 2001, which is a continuation, under 35 U.S.C. §120, of prior PCT International Application No. PCT/AU98/00642 which has an International filing date of Aug. 13, 1998, which designated the United States of America, and which was published by the International Bureau in English on Feb. 25, 1999, and which claims the benefit of Australian Provisional Application No. PO 8558 filed Aug. 13, 1997.

This invention relates to a method for analysing the concentration of an analyte in a sample and to automatic analysing apparatus. The invention will be described herein with particular reference to a method and apparatus for measuring the concentration of glucose or other analytes in blood but is not limited to that use.

In our copending applications PCT/AU/00365, PCT/AU/00723, and PCT/AU/00724 (the disclosures of which are incorporated herein by reference) we have described a method for determining the concentration of an analyte in a carrier. In that method a sample to be analysed is brought into contact with a reagent containing an enzyme and a redox mediator in an electrochemical cell. The cell is a thin layer cell comprising a working electrode spaced apart from a counter electrode by a spacer which ensures that the two electrodes have substantially identical area and predetermined spacing. The spacing between the electrodes is essentially close so that after a potential is applied between the electrodes, reaction products from the counter electrode migrate to the working electrode and vice versa, eventually establishing a steady state concentration profile between the electrodes which in turn results in a steady state current.

It has been found that by comparing a measure of the steady state current with the time rate at which the current varies in the current transient before the steady state is achieved, the diffusion coefficient of the redox mediator can be measured as well as its concentration. It can be shown that over a restricted time range a plot a ln(i/iss−1) vs time (measured in seconds) is linear and has a slope (denoted by S) which is equal to −4 p2D/L, where “i” is the current at time “t”, “iss” is the steady state current, “D” is the diffusion coefficient in cm2/sec, “L” is the distance between the electrodes in cm and “p” is the constant pi, approximately 3.14159. The concentration of reduced mediator present when the potential was applied between the electrodes is given by −2 p2iss/FALS, where “F” is Faraday's constant, A is the working electrode area and the other symbols are as given above. As this later formula uses S it includes the measured value of the diffusion coefficient.

Since L and the electrode area are constants for a given cell, measurement of i as a function of time and iss enable the value of the diffusion coefficient of the redox mediator to be calculated and the concentration of the analyte to be determined. In our copending application PCT/AU/00724 there are described methods suitable for mass production of cells having a substantially constant electrode separation L and electrode area A.

Currently glucose in blood samples is measured in pathology laboratories and the like by means of apparatus such the YSI blood analyser in which successive samples are analysed by means of a hollow cylindrical probe in which is mounted a silver and a platinum electrode. The face of the probe is fitted with a three layer membrane. The middle layer contains an immobilized enzyme which is sandwiched between a cellulose acetate and a polycarbonate membrane. The face of the probe, covered by the membrane, is situated in a buffer filled sample chamber into which successive samples are injected. Some of the sample diffuses through the membrane. When it contacts the immobilised oxidase enzyme it is rapidly oxidised producing hydrogen peroxide, the glucose forming a glucono-delta-lactone.

The hydrogen peroxide is in turn oxidised at the platinum anode producing electrons. A dynamic equilibrium is achieved when the rate of peroxide production and removal reach a steady state. The electron flow is linearly proportioned to the steady state peroxide concentration and therefore to the concentration of the glucose.

The platinum electrode is held at an anodic potential and is capable of oxidising many substances other than hydrogen peroxide. To prevent these reducing agents from contribution to sensor current, the membrane contains an inner layer consisting of a very thin film of cellulose acetate. This film readily passes hydrogen peroxide but excludes chemical compounds with molecular weights above approximately 200. The acetate film also protects the platinum surface from proteins, detergents, and other substances that could foul it. However the cellulose acetate film can be penetrated by compounds such as hydrogen sulphide, low molecular weight mercaptans, hydroxylamines, hydrozines, phenols and analytes.

In use, the sample (or a calibration standard) is dispensed in to the chamber, diluted into 600 microliters of buffer, and then a measurement is made by the probe. The sensor response increases and then reaches a plateau when a steady state is reached. After several seconds a buffer pump flushes the chamber and the sensor response decreases.

The apparatus monitors the base line current. If it is unstable a buffer pump will continue to flush the sample chamber with buffer. When a stable base line is established an automatic calibration is initiated. The apparatus calibrates itself for example after every five samples or 15 minutes. If a difference of more than 2% occurs between the present and previous calibration, the apparatus repeats the calibration. Recalibration also occurs if the sample chamber temperature drifts by more than 1° C.

The apparatus described suffers from a number of disadvantages. Firstly, a high proportion of its time in use is spent in performing calibrations rather than analysis. Furthermore the consumption of buffer and calibrating solutions is a substantial cost. Another disadvantage is that as the enzyme membrane ages, a graph of reading versus concentration becomes non-linear. It would be highly desirable to provide apparatus which is able to make measurements of the kind described with improved speed, efficiency, and at lower running cost.

An object of the present invention is an improved method and apparatus for automatically analysing samples which avoids or ameliorates at least some of the disadvantages of prior art. An object of the preferred embodiment of the invention is an automatic apparatus for estimating the concentration of glucose in samples of blood.

According to a first aspect the invention consists in a method for estimating the concentration of a reduced (or oxidised) form of a redox species in a liquid comprising the steps of:

According to a second aspect the invention consists in automatic analysing apparatus comprising:

Various embodiments of the invention will now be described by way of example only with reference to the accompanying drawings wherein:

FIG. 1 is a schematic diagram showing in cross-section a first embodiment of apparatus according to the invention.

FIG. 2 is a schematic diagram showing, in enlarged cross-section, a sample droplet between two electrodes.

FIG. 3 is a schematic diagram showing in cross-section a second embodiment of apparatus according to the invention.

FIG. 4 is a schematic diagram of a third embodiment of apparatus according to the invention in side elevation.

FIG. 5 shows the embodiment of FIG. 4 in end elevation, viewed on line 55 of FIG. 4.

By way of example a first embodiment of apparatus according to the invention will be described.

With reference to FIG. 1 there is shown schematically an automatic analyser for measuring glucose in blood samples. The apparatus comprises a flexible first electrode 1 consisting of a palladium layer 2 formed or deposited onto a flexible carrier 3 (for example a 100 micron PET film) preferably by sputter coating to a thickness of for example 100-1000 angstrom. Electrode 1 is fed into the analyser from a roll (not illustrated) in the form of a tape.

First electrode 1 is provided on palladium surface 2 with an enzyme and a redox mediator. These may be selected (without limitation) from the systems in table 1 and in the present example a GOD enzyme and ferricyanide mediator are used. The enzyme and redox mediator may be printed in predetermined quantities at predetermined intervals on the first electrode surface as a dried reagent coating 4.

Electrode 1 is driven by means not shown in the drawings through a sample station “S” at which a precise volume of a sample 1 is placed as a droplet 5 on a reagent coating 4 on electrode surface 1, for example, by means of an automatic pipette 6. Less preferably, predetermined quantities of enzyme and redox mediator may be combined with the sample before or after deposition of the droplet on the electrode.

A second electrode 11 which in the present example is of similar construction to the first electrode, and comprising a palladium layer 12 sputter coated onto a flexible PET carrier 13, is then brought into closely spaced relationship with electrode 1 and into contact with a droplet 5. The droplet wets both palladium surfaces 1 and 10 and adopts a substantially cylindrical configuration between the two electrodes as more clearly illustrated in FIG. 2. The droplet is bounded intermediate electrodes 1, 2 by a liquid/gas interface 14.

An electric potential is then applied to the two electrodes (by means not illustrated in FIG. 1) via contacts.

As described in our co-pending applications PCT/AU96/00723 and PCT/AU96/00724, the potential between the electrodes is set such that the rate of electro-oxidation of the reduced form of the species (or of electro-reduction of the oxidised form) is diffusion controlled. Because the working and counter electrodes are placed in very close proximity (about 0.5 mm apart or less) ferricyanide that is generated at the counter electrode has time to reach the working electrode and contribute to the current at the working electrode. That is, a ferricyanide molecule can be reduced at the counter electrode to ferrocyanide, and can then diffuse to the working electrode, where it will be re-oxidised to ferricyanide. This situation results in a decreasing current at short times that steadies to reach a constant value at longer times (the steady state current). This steadying of the current occurs because a constant stream of ferrocyanide is being supplied to the working electrode from the counter electrode. This mechanism is quite distinct from that which occurs in a Cottrell device in which the electrodes are separated so that ferricyanide that results from the reduction of ferricyanide at the counter electrode does not influence the observed current.

In the present cell the steady state current is given by i ss = 2 DFAC 0 L ( 1 )
wherein iss is the steady state current, D is the diffusion coefficient, F is the Faraday constant, A is the area of the electrode, C0 is the concentration of the analyte (ferricyanide) and L is the separation of the electrodes.

The current i at time t is given by the equation: i = i ss ( 1 + 2 n = 1 e - 4 p 2 n 2 Dt L 2 ) ( 2 )
where p is pi.
At longer times the higher exponential terms in equation 2 can be ignored. Therefore equation 2 can be approximated by equation 3 for times greater than a certain value i = i ss ( 1 + 2 exp ( - 4 p 2 Dt L 2 ) ) ( 3 )

If it is assumed that equation 2 can be approximated by equation 3 when the second exponential term in equation 2 is 1% of the first exponential term, equation 3 is valid for times greater than t = 0.0389 L 2 D .

It will be understood that Equation 3 can be transformed to give: ln ( i iss - 1 ) = ln ( 2 ) - 4 p 2 Dt L 2 ( 4 )

So a plot of the left hand side of equation (4′) versus time will give a straight line with new slope = - 4 p 2 Dt L 2 ( 5 )
Combining equations (1) and (5′) gives Co = - 2 p 2 iss FVslope ( 6 )
where V=AL is the volume of the drop of sample pipetted onto the tape. Since the parameters “slope” and “iss” are measured in the test and p and F are universal constants, to measure the concentration of the analyte derived from the test (Co) it is only required to know the volume of the sample pipetted. Since this can be done very accurately it is possible to have a very accurate measure of Co without the need for any other calibration of the system. Significantly, neither the spacing between the electrodes nor the electrode area wetted need be known.

The exact shape adopted by the droplet in contact with the two electrodes is not important.

If desired the chemistry of successive electrode locations could be different one from another so that a multiplicity of different tests could be performed on successive pipetted volumes of sample placed at successive electrode locations. In a second embodiment as shown in FIG. 3 which corresponds to the portion of FIG. 1 upstream from sample station S, the first electrode is provided with an overlying layer 7 for example of a thin PET film from which apertures have been punched to define wells 8 into which chemical reagents 4 can be placed, and which served to define the locations at which reagents have been placed and/or to protect the reagents prior to use. In this case electrode 1 is conveniently supplied to the apparatus from a roll having predetermined quantities of chemical reagents in the wells in dried form and protected from contamination prior to use by being sandwiched between layers of the roll. The chemical reagents are only used once and therefore can be more easily protected against deterioration than is possible with prior art. In the above described embodiment the sample droplet 5 is not “contained” by a cell although it may be deposited and located within a well 8. When a well-defining layer 7 is employed it may be adhered to the electrode surface or electrode carrier or it may merely be a non-adhered spacer layer.

It is not necessary for the upper electrode layer 11 to come into contact with the top surface of the well-defining layer 7 The volume of sample pipetted is such that the height of drop 5 is equal to or preferably greater than the thickness of the well-defining layer 7. If a layer 7 is used to define a well 8, it is undesirable for the sample volume to run to the sides of the well. It is sufficient that the sample is a known volume and wets both electrodes preferably forming a substantially cylindrical shape therebetween.

It will also be understood that the well-defining layer 7 can be replaced with a porous layer for example a porous paper, non-woven mesh, or felt, or a porous membrane, which acts to immobilise the sample spatially with respect to the electrode layers and to hold the reagents in place and in this case the second electrode will contact the surface of the porous layer immobilising the volume.

It will be understood that use of a porous or well-defining layer 7 is optional and that in other embodiments of the invention a layer 7 is unnecessary it being sufficient for a drop of sample to be pipetted onto a metal layer 2 and for an upper metal layer 12 to be brought into contact with a sample drop of predetermined volume, upper metal layer 12 being desirably but not essentially at a predetermined spacing from the lower metal layer 1.

It will also be understood that the metal layer tapes or bands need not be travelling in the same direction. For example, one metallised electrode layer may be proceeding transversely of the other, each tape being advanced after each measurement to expose a fresh lower and fresh upper electrode surface and fresh reagent at the sample filling station. In each case the resulting current is measured as a function of time while the electrodes are in contact with a sample drop of predetermined volume.

Continuous band electrodes are preferred. These may either be disposed of after use or may be passed through a washing station and then reused, if desired after reprinting with reagents.

In preferred embodiments of the invention predetermined quantities of reagent are placed on one or both of the electrodes by metering devices for example an ink jet print-head upstream of sample station 3 and may, but need not, be dried prior to contact with the sample. A reagent application system may be a part of the apparatus, or the apparatus may be adapted to receive electrodes in roll or other form pretreated with the desired reagents at another location or plant.

It will be understood that one or both electrodes need not be a continuous band but may, for example, be in the form of a retractable probe. The second electrode could be a disposable probe lowered into contact with a droplet on a first electrode and then withdrawn after current measurements are completed. Likewise the first electrode need not be in the form of a tape. The first electrode could for example be mounted to a carousel or be in the form of a rotating disc. Although it is preferred to use disposable electrode surfaces, the method may be applied with reusable electrodes washed in between successive uses. By way of example, there is shown schematically in FIG. 4 an automatic analysing apparatus comprising a first electrode 1 in the form of a first disc driven intermittently in rotation about a first horizontal axis. A second electrode 11 is driven intermittently and synchronously with the first disc in rotation about a horizontal axis parallel to the first axis. Electrodes 1 and 11 are spaced apart at their edge at the closest point of approach. Sample drops 5 of precisely predetermined volume are deposited on the first electrode at intervals by a pipetting device 6 in synchronisation with the disc rotation. Reagents 4 are printed on the second electrode at corresponding intervals by means of a printing roll 16 and are dried in situ, for example by an air blower (not shown in the drawing).

In use, as electrode 1 rotates, a drop 5 travels to a position where it comes into contact with the second electrode and with the reagents printed thereupon. While both discs are stationary with the droplet in contact with each electrode, a potential is applied between the electrodes and the current measured as previously discussed. During this time the reagent(s) dissolve in the sample and after the necessary measurements have been made, both electrodes are indexed to a new angle of rotation. The surfaces used for the analysis are washed clean by sprays 14, into drained sumps 15 and ready for reuse.

Apparatus according to the invention requires very much smaller samples than are required with the YSI device and because the chemical reagents can be better protected until used and more accurately metered, the apparatus provides greater accuracy and speed at reduced cost.

In another embodiment of the invention the current can be followed with time after a potential has been applied between the electrodes until a predetermined time or state has been reached. The sign of the applied potential would then be reversed and analysis performed similar to that given above except with equations (3) and (4) being replaced with i = iss ( 1 + 4 exp ( - 4 p 2 Dt L 2 ) ) ( 7 ) ln ( i iss - 1 ) = ln ( 4 ) - 4 p 2 Dt L 2 ( 8 )

This protocol has the advantage of being able to allow for slow processes occurring in the test. This can be done by:

Although the invention has been described with reference to palladium electrodes, the electrodes can be of other suitable metals such as described for example in our earlier applications referred to herein. One electrode may be different from the other. The electrodes may be supported by PET as exemplified above or by other suitable insulating materials or may be self-supporting. If supported on an insulating film, it is preferred, but not essential, that the metals be deposited on the film by sputter coating. Electrical contact for the application of a potential and/or for the measurement of current may be by any suitable means including clamping engagement with one end of the electrode if in the form of a tape, or by means of suitable rolling contacts, or springloaded contacts, or the like. The application of the electrical potential; the measurement of current; the calculation of the concentration of analyte; the synchronous control of the movement of one electrode with respect to the other and with the deposition of sample droplets and, if required, with the deposition of reagents may be controlled by a microprocessor or the like and the results may be printed, displayed, and/or otherwise recorded by means which are well-known to those skilled in the control arts.

As will be appreciated by those skilled in the art from the teaching hereof the features of one embodiment may be combined with those of another and the invention may be embodied in other forms without departing from the concepts herein disclosed.

TABLE 1
REDOX MEDIATOR
ANALYTE ENZYMES (OXIDISED FORM) ADDITIONAL MEDIATOR
Glucose GDHpqq Ferricyanide
Glucose (NAD dependent) Glucose dehydrogenase and diaphorase Ferricyanide
Cholesterol Cholesterol esterase and cholesterol Ferricyanide 2,6-dimethly-1,4-benzoquinone 2,5-
oxidase dichloro-1,4-benzoquinone or
phenazine ethosulfate
HDL cholesterol Cholesterol esterase and cholesterol Ferricyanide 2,6-dimethly-1,4-benzoquinone 2,5-
oxidase dichloro-1,4-benzoquinone or
phenazine ethosulfate
Triglycerides Lipoprotein lipase, glycerol kinase, and Ferricyanide or phenazine ethosulphate Phenazine methosulfate
glycerol-3-phosphate oxidase
Lactate Lactate oxidase Ferricyanide 2,6-dicholoro-1,4-benzoquinone
Lactate Lactate dehydrogenase and diaphorase Ferricyanide, phenazine ethosulfate, or
phenazine methosulfate
Lactate dehydrogenase Diaphorase Ferricyanide, phenazine ethosulfate, or
phenazine methosulfate
Pyruvate Pyruvate oxidase Ferricyanide
Alcohol Alcohol oxidase Phenylenediamine
Bilirubin Bilirubin oxidase 1-methoxy-phenazine methosulfate
Uric acid Uricase Ferricyanide

Maxwell, Ian Andrew, Hodges, Alastair McIndoe, Beck, Thomas William

Patent Priority Assignee Title
10034628, Dec 12 2005 Sanofi-Aventis Deutschland GmbH Low pain penetrating member
7875047, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
7892183, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
7901365, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7909774, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7909775, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
7909777, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7909778, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7914465, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7938787, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7959582, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7976476, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Device and method for variable speed lancet
7981055, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
7981056, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
7988644, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
7988645, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
8007446, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8016774, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8062231, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8079960, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8123700, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
8157748, Apr 16 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8162853, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8197421, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8197423, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8202231, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8206317, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8206319, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8211037, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8216154, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8221334, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8235915, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8251921, Jun 06 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
8262614, Jun 01 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for fluid injection
8267870, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling with hybrid actuation
8282576, Sep 29 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for an improved sample capture device
8282577, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
8296918, Dec 31 2003 Sanofi-Aventis Deutschland GmbH Method of manufacturing a fluid sampling device with improved analyte detecting member configuration
8333710, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8337419, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8337420, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8337421, Oct 04 2005 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8343075, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8360991, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8360992, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8366637, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8372016, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
8382682, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8382683, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8388551, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for multi-use body fluid sampling device with sterility barrier release
8403864, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8414503, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8430828, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
8435190, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8439872, Mar 30 1998 Sanofi-Aventis Deutschland GmbH Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
8491500, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8496601, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8556829, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8562545, Oct 04 2005 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8574168, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with analyte sensing
8574895, Dec 30 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus using optical techniques to measure analyte levels
8579831, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8622930, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8636673, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8641643, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Sampling module device and method
8641644, Nov 21 2000 Sanofi-Aventis Deutschland GmbH Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
8652831, Dec 30 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for analyte measurement test time
8668656, Dec 31 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
8679033, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8690796, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8702624, Sep 29 2006 Sanofi-Aventis Deutschland GmbH Analyte measurement device with a single shot actuator
8721671, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Electric lancet actuator
8784335, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling device with a capacitive sensor
8808201, Apr 19 2002 SANOFI S A ; Sanofi-Aventis Deutschland GmbH Methods and apparatus for penetrating tissue
8828203, May 20 2005 SANOFI S A Printable hydrogels for biosensors
8845549, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method for penetrating tissue
8845550, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8905945, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8945910, Sep 29 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for an improved sample capture device
8965476, Apr 16 2010 Pelikan Technologies, Inc Tissue penetration device
9034639, Dec 30 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus using optical techniques to measure analyte levels
9072842, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9089294, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Analyte measurement device with a single shot actuator
9089678, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9144401, Dec 12 2005 Sanofi-Aventis Deutschland GmbH Low pain penetrating member
9186468, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9226699, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling module with a continuous compression tissue interface surface
9248267, Oct 04 2005 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
9261476, May 20 2004 Sanofi SA Printable hydrogel for biosensors
9314194, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
9339612, Oct 04 2005 Sanofi-Aventis Deutschland GmbH Tissue penetration device
9351680, Oct 14 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for a variable user interface
9375169, Jan 30 2009 Sanofi-Aventis Deutschland GmbH Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
9386944, Apr 11 2008 Sanofi-Aventis Deutschland GmbH Method and apparatus for analyte detecting device
9427532, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
9498160, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method for penetrating tissue
9560993, Nov 21 2001 Sanofi-Aventis Deutschland GmbH Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
9561000, Dec 31 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
9694144, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Sampling module device and method
9724021, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9775553, Jun 03 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for a fluid sampling device
9795334, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9795747, Jun 02 2010 Pelikan Technologies, Inc Methods and apparatus for lancet actuation
9802007, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
9820684, Jun 03 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for a fluid sampling device
9839386, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling device with capacitive sensor
9907502, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9937298, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
Patent Priority Assignee Title
3552928,
4053381, May 19 1976 Eastman Kodak Company Device for determining ionic activity of components of liquid drops
4076596, Oct 07 1976 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
4125372, Apr 01 1975 Kabushiki Kaisha Kyoto Kaiichi Kagaku Method and device for testing liquids
4168146, Jan 27 1975 Dade Behring Marburg GmbH Immunoassay with test strip having antibodies bound thereto
4224125, Sep 28 1977 Matsushita Electric Industrial Co., Ltd. Enzyme electrode
4225557, Jul 01 1977 Rohm GmbH Packaged diagnostic test strip
4259165, Dec 20 1978 Hokushin Electric Works, Ltd. Dissolved oxygen probe
4301412, Oct 29 1979 United States Surgical Corporation Liquid conductivity measuring system and sample cards therefor
4301414, Oct 29 1979 United States Surgical Corporation Disposable sample card and method of making same
4303887, Oct 29 1979 United States Surgical Corporation Electrical liquid conductivity measuring system
4319969, Aug 31 1979 Asahi Glass Company, Ltd. Aqueous alkali metal chloride electrolytic cell
4374013, Mar 06 1980 Oxygen stabilized enzyme electrode
4404066, Aug 25 1980 YSI, INCORPORATED Method for quantitatively determining a particular substrate catalyzed by a multisubstrate enzyme
4431004, Oct 27 1981 Implantable glucose sensor
4431507, Jan 14 1981 Matsushita Electric Industrial Co., Ltd. Enzyme electrode
4508613, Dec 19 1983 SPECTRAMED, INC Miniaturized potassium ion sensor
4508821, Jul 05 1983 Becton Dickinson and Company Detection of white cell associated bacteria with a fluorescent dye
4517287, Apr 04 1979 Boehringer Mannheim GmbH Method and reagent for the enzymatic determination of enzyme substrates
4517291, Aug 15 1983 DADE BEHRING INC ; BADE BEHRING INC Biological detection process using polymer-coated electrodes
4533440, Aug 04 1983 General Electric Company Method for continuous measurement of the sulfite/sulfate ratio
4545382, Oct 23 1981 MEDISENSE, INC Sensor for components of a liquid mixture
4552840, Dec 02 1982 California and Hawaiian Sugar Company Enzyme electrode and method for dextran analysis
4604264, Dec 23 1982 Boehringer Mannheim GmbH Test strips
4637978, Oct 28 1983 CLINICAL DIAGNOSTIC SYSTEMS INC Assay for analysis of whole blood
4654197, Oct 18 1983 MIGRATA U K LIMITED Cuvette for sampling and analysis
4711245, Oct 22 1982 MEDISENSE, INC Sensor for components of a liquid mixture
4790979, Aug 29 1986 HOME DIAGNOSTICS, INC Test strip and fixture
4797256, Jun 05 1987 Roche Diabetes Care, Inc Registration device for blood test strips
4820489, Dec 23 1982 Boehringer Mannheim GmbH Test strips and a process for the production thereof
4871258, Apr 29 1988 Roche Diabetes Care, Inc Color test meter
4874501, Jun 18 1985 Radiometer A/S Membrane for an electrochemical measuring electrode device
4883764, Jul 20 1987 Blood test strip
4897173, Jun 21 1985 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
4900424, Nov 28 1986 Inverness Medical Switzerland GmbH Electrochemical measurement cell
4919770, Jul 30 1982 Siemens Aktiengesellschaft Method for determining the concentration of electro-chemically convertible substances
4943522, Jun 01 1987 Quidel Lateral flow, non-bibulous membrane assay protocols
4963815, Feb 10 1987 MOLECULAR DEVICES, CORPORATION, 3180 PORTER DRIVE, PALO ALTO, CA 94304, A CA CORP Photoresponsive electrode for determination of redox potential
4988429, Jun 30 1989 Dragerwerk Aktiengesellschaft Measuring cell for an electrochemical gas sensor
4994238, Jun 09 1988 Roche Diabetes Care, Inc Constant volume chemical analysis test device
5059908, May 31 1990 Capital Controls Company, Inc. Amperimetric measurement with cell electrode deplating
5096809, Jul 25 1988 Quidel Corporation Whole blood assays using porous membrane support devices
5120420, Mar 31 1988 MATSUSHITA ELECTRIC INDUSTRIAL CO , LTD Biosensor and a process for preparation thereof
5122244, Feb 03 1990 Boehringer Mannheim GmbH Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
5126034, Jul 21 1989 MEDISENSE, INC , CAMBRIDGE, MA A CORP OF MA Bioelectrochemical electrodes
5128015, Mar 15 1988 Roche Diabetes Care, Inc Method and apparatus for amperometric diagnostic analysis
5156972, Sep 05 1989 The State of Israel, Atomic Energy Commission, Soreq Nuclear Research Analyte specific chemical sensor with a ligand and an analogue bound on the sensing surface
5179005, Aug 13 1986 LifeScan, Inc. Minimum procedure system for the determination of analytes
5185256, Jun 21 1985 Matsushita Electric Industrial Co., Ltd. Method for making a biosensor
5192415, Mar 04 1991 MATSUSHITA ELECTRIC INSTRIAL CO , LTD Biosensor utilizing enzyme and a method for producing the same
5229282, Nov 24 1989 Matsushita Electric Industrial Co., Ltd. Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system
5264103, Oct 18 1991 Panasonic Corporation Biosensor and a method for measuring a concentration of a substrate in a sample
5272087, Apr 20 1988 GWENT SENSORS LTD Enzymatic electrode and its preparation method
5286362, Feb 03 1990 Boehringer Mannheim GmbH Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
5288403, Feb 28 1992 Nissoh Corporation Filter for removing leucocytes
5288636, Dec 15 1989 Roche Diagnostics Corporation Enzyme electrode system
5290420, Aug 12 1992 ESA BIOSCIENCES, INC Sampling system and analysis cell for stripping voltammetry
5306623, Aug 28 1989 LifeScan, Inc. Visual blood glucose concentration test strip
5312590, Apr 24 1989 National University of Singapore, The Amperometric sensor for single and multicomponent analysis
5314605, Jun 30 1989 Dragerwerk Aktiengesellschaft Measuring cell for electrochemically detecting a gas
5320732, Jul 20 1990 Matsushita Electric Industrial Co., Ltd. Biosensor and measuring apparatus using the same
5322610, Oct 19 1990 OLYMPUS OPTICAL CO , LTD , Automatic ion concentration analyzing apparatus
5348630, Nov 29 1988 NGK Spark Plug Co., Ltd. Method of measuring humidity using an electrochemical cell
5382346, May 17 1991 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
5384028, Aug 28 1992 NEC Corporation Biosensor with a data memory
5385846, Jun 03 1993 Roche Diabetes Care, Inc Biosensor and method for hematocrit determination
5393399, Sep 07 1992 Gie Cylergie Amperometric measuring device having an electrochemical sensor
5405511, Jun 08 1993 Roche Diabetes Care, Inc Biosensing meter with ambient temperature estimation method and system
5413690, Jul 23 1993 Roche Diabetes Care, Inc Potentiometric biosensor and the method of its use
5418142, Aug 28 1989 LifeScan, Inc. Glucose test strip for whole blood
5437999, Feb 22 1994 Roche Diabetes Care, Inc Electrochemical sensor
5508171, Dec 15 1989 Roche Diabetes Care, Inc Assay method with enzyme electrode system
5509410, Jun 06 1983 MediSense, Inc. Strip electrode including screen printing of a single layer
5518590, Jun 21 1994 Pennzoil Products Company Electrochemical sensors for motor oils and other lubricants
5520787, Feb 09 1994 Abbott Laboratories Diagnostic flow cell device
5567302, Jun 07 1995 Molecular Devices Corporation Electrochemical system for rapid detection of biochemical agents that catalyze a redox potential change
5611908, Dec 22 1994 Dr agerwerk Aktiengesellschaft Method of operating and amperometric measuring cell
5620579, May 05 1995 Bayer Corporation Apparatus for reduction of bias in amperometric sensors
5628890, Sep 27 1995 MEDISENSE, INC Electrochemical sensor
5645709, Dec 08 1993 VAN DEN BERGH FOODS CO , DIVISION OF CONOPCO, INC Methods and apparatus for electrochemical measurements
5863400, Apr 14 1994 Lifescan, Inc Electrochemical cells
5942102, Nov 15 1996 Lifescan, Inc Electrochemical method
5965456, Jun 11 1992 GE Healthcare Bio-Sciences AB Analyte detection
5997817, Dec 05 1997 Roche Diabetes Care, Inc Electrochemical biosensor test strip
6077408, Jan 31 1997 PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD Biosensor and method of manufacturing the same
6325917, Aug 13 1997 Lifescan, Inc Method and apparatus for automatic analysis
AU3104293,
AU5487394,
EP10457,
EP127958,
EP206218,
EP251915,
EP255291,
EP278647,
EP345781,
EP351516,
EP400918,
EP407800,
EP415679,
EP418404,
EP475692,
EP479394,
EP537761,
EP560336,
EP574134,
EP593096,
EP732406,
EP741186,
EP764469,
EP964059,
GB2201248,
JP593345,
JP6310746,
WO9700441,
WO8908713,
WO9215701,
WO9402842,
WO9503543,
WO9516198,
WO9521934,
WO9528634,
WO9718464,
WO9718465,
WO9811426,
WO9835225,
WO9843073,
WO9843074,
WO9946585,
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 02 2001LifeScan, Inc.(assignment on the face of the patent)
Jan 16 2002USF FILTRATION AND SEPARATIONS GROUP INC Lifescan, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0135420973 pdf
Date Maintenance Fee Events
Jul 22 2008M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Sep 24 2012REM: Maintenance Fee Reminder Mailed.
Feb 08 2013EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Feb 08 20084 years fee payment window open
Aug 08 20086 months grace period start (w surcharge)
Feb 08 2009patent expiry (for year 4)
Feb 08 20112 years to revive unintentionally abandoned end. (for year 4)
Feb 08 20128 years fee payment window open
Aug 08 20126 months grace period start (w surcharge)
Feb 08 2013patent expiry (for year 8)
Feb 08 20152 years to revive unintentionally abandoned end. (for year 8)
Feb 08 201612 years fee payment window open
Aug 08 20166 months grace period start (w surcharge)
Feb 08 2017patent expiry (for year 12)
Feb 08 20192 years to revive unintentionally abandoned end. (for year 12)